-
Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis
-Results of a new study 1 presented today at the United European Gastroenterology Week (UEGW) congress in Stockholm demonstrate…
0 -
Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.
-Ferring Pharmaceuticals (Ferring) announced today that it has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its…
Archive for October, 2011
2011 > October